December 14, 2023 12:21 PM ESTUpdated 03:59 PM

Sanofi and AstraZeneca to make 230,000 additional RSV immunizations available, White House says

Lia DeGroot

RSV vaccine manufacturers Sanofi and AstraZeneca will make 230,000 more doses of their immunizations for infants available beginning in January to address high demand, the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Sanofi and AstraZeneca to make 230,000 additional RSV immunizations available, White House says

Lia DeGroot

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Updated: Patient dies in Rocket gene therapy trial, which is put on clinical hold by FDA

Lilly to buy non-opioid pain biotech SiteOne for up to $1B

RFK Jr. ends annual Covid vaccine recommendations for kids, pregnant women

Investors pump $130M into protein degrader startup GlycoEra

Prothena’s amyloidosis drug flops again, spending and staff cuts are on the way

From weeks to days: how Aizon Intelligent Agents transform pharma validation

Sanofi and As­traZeneca to make 230,000 ad­di­tion­al RSV im­mu­niza­tions avail­able, White House says

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Sanofi and AstraZeneca to make 230,000 additional RSV immunizations available, White House says